<efrbr:recordSet xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:efrbr="http://vfrbr.info/efrbr/1.1" xmlns:efrbr-work="http://vfrbr.info/efrbr/1.1/work" xmlns:efrbr-expression="http://vfrbr.info/efrbr/1.1/expression" xmlns:efrbr-manifestation="http://vfrbr.info/efrbr/1.1/manifestation" xmlns:efrbr-person="http://vfrbr.info/efrbr/1.1/person" xmlns:efrbr-corporateBody="http://vfrbr.info/efrbr/1.1/corporateBody" xmlns:efrbr-concept="http://vfrbr.info/efrbr/1.1/concept" xmlns:efrbr-structure="http://vfrbr.info/efrbr/1.1/structure" xmlns:efrbr-responsible="http://vfrbr.info/efrbr/1.1/responsible" xmlns:efrbr-subject="http://vfrbr.info/efrbr/1.1/subject" xmlns:efrbr-other="http://vfrbr.info/efrbr/1.1/other" xsi:schemaLocation="http://vfrbr.info/efrbr/1.1 http://vfrbr.info/schemas/1.1/efrbr.xsd"><efrbr:entities><efrbr-work:work identifier="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569"><efrbr-work:titleOfTheWork>Synthesis, characterization, and biocompatibility studies of a new lanthanum-cerium synthetic aminoclay analogue</efrbr-work:titleOfTheWork></efrbr-work:work><efrbr-expression:expression identifier="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569"><efrbr-expression:titleOfTheExpression>Synthesis, characterization, and biocompatibility studies of a new lanthanum-cerium synthetic aminoclay analogue</efrbr-expression:titleOfTheExpression><efrbr-expression:formOfExpression vocabulary="DIAS:TYPES">
            Peer-Reviewed Journal Publication
            Δημοσίευση σε Περιοδικό με Κριτές
         </efrbr-expression:formOfExpression><efrbr-expression:dateOfExpression type="issued">2025-09-11</efrbr-expression:dateOfExpression><efrbr-expression:dateOfExpression type="published">2023</efrbr-expression:dateOfExpression><efrbr-expression:languageOfExpression vocabulary="iso639-1">en</efrbr-expression:languageOfExpression><efrbr-expression:summarizationOfContent>Aminopropyl-functionalized synthetic phyllosilicate analogues have been widely used in many biological and medical applications due to their facile, green, simple and at ambient conditions synthetic procedure. Furthermore, rare earth synthetic aminoclay analogues could have great potential as antibacterial agents, since rare earth ions (III) have a high binding affinity to phosphate groups, while the amine groups can be spontaneously protonated in any aquatic environment causing the depolarization of the bacterial membrane structure via electrostatic forces. Herein, we designed and successfully prepared a new Lanthanum/Cerium synthetic aminoclay analogue (LaCeAC) and studied the in vitro effects in normal and cancer cells. Our results showed a differential effect in each cell line underlying however a common cytotoxic mechanism: the generation of reactive oxygen species (ROS) which was significantly higher and more detrimental to the normal cells. The resilience of cancer cells could be attributed to the milder effect of LaCeAC on their membrane structure, resulting in lower endocytosis (uptake) rates compared to normal cells.</efrbr-expression:summarizationOfContent><efrbr-expression:useRestrictionsOnTheExpression type="creative-commons">http://creativecommons.org/licenses/by/4.0/</efrbr-expression:useRestrictionsOnTheExpression><efrbr-expression:note type="journal name">Applied Materials Today</efrbr-expression:note><efrbr-expression:note type="journal volume">35</efrbr-expression:note></efrbr-expression:expression><efrbr-person:person identifier="2A62AA50-C78D-43BC-9B3F-5BAC79C39E33"><efrbr-person:nameOfPerson vocabulary="">
            Kaloudi Angela S.
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="50605E6C-A649-461E-A906-1CB066EA6201"><efrbr-person:nameOfPerson vocabulary="">
            Athinodorou Antrea Maria
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="E519FB47-4400-445E-B2BC-F97F938640DD"><efrbr-person:nameOfPerson vocabulary="">
            Spyrou Konstantinos
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="7E9E5222-5CB6-4F06-863D-6F55367972C8"><efrbr-person:nameOfPerson vocabulary="">
            Simos Yannis V.
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="B83DBACF-37F3-49C1-87A3-CB26D927DF24"><efrbr-person:nameOfPerson vocabulary="">
            Zygouri Panagiota
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="E840FF49-B85D-4CA0-8521-7C1B22819928"><efrbr-person:nameOfPerson vocabulary="">
            Hammami Mohamed Amen
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="63B72931-7075-470A-88DE-10819E279D9F"><efrbr-person:nameOfPerson vocabulary="">
            Datta K. K. R.
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="2565493B-B9C1-4217-A547-D92074DF73D9"><efrbr-person:nameOfPerson vocabulary="">
            Vezyraki Patra E.
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="CD9A1808-7F81-41CA-965A-6D9AD3C49628"><efrbr-person:nameOfPerson vocabulary="">
            Peschos Dimitrios
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="2E288A78-F046-4A5F-B4E4-D16514349133"><efrbr-person:nameOfPerson vocabulary="">
            Tsamis Konstantinos
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-person:person identifier="http://users.isc.tuc.gr/~dgournis"><efrbr-person:nameOfPerson vocabulary="TUC:LDAP">
            Gournis Dimitrios
            Γουρνης Δημητριος
         </efrbr-person:nameOfPerson></efrbr-person:person><efrbr-corporateBody:corporateBody identifier="https://v2.sherpa.ac.uk/id/publisher/30"><efrbr-corporateBody:nameOfTheCorporateBody vocabulary="S/R:PUBLISHERS">
            Elsevier
         </efrbr-corporateBody:nameOfTheCorporateBody></efrbr-corporateBody:corporateBody><efrbr-concept:concept identifier="CED34722-0D20-469D-88B7-969724B63AA2"><efrbr-concept:termForTheConcept>
            Lanthanum/Cerium aminoclay
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="92911702-2B56-4454-A8CF-0480A801F200"><efrbr-concept:termForTheConcept>
            Biocompatibility
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="519EECC1-6AA9-46A6-BBAC-0BF451BA694E"><efrbr-concept:termForTheConcept>
            Cytotoxicity
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="F0A68654-65F9-4775-B1E8-1AD873275EFD"><efrbr-concept:termForTheConcept>
            Permeability
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="C3CFDD3A-6106-44D2-B41F-BB54241D9EA5"><efrbr-concept:termForTheConcept>
            Cell membrane
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="3A6BE53C-2AE2-45A7-A014-D84DF043009F"><efrbr-concept:termForTheConcept>
            Oxygen species
         </efrbr-concept:termForTheConcept></efrbr-concept:concept><efrbr-concept:concept identifier="EDE9CB4B-9596-48A8-8551-93A2405BC8E6"><efrbr-concept:termForTheConcept>
            Reactive
         </efrbr-concept:termForTheConcept></efrbr-concept:concept></efrbr:entities><efrbr:relationships><efrbr-structure:structureRelations><efrbr-structure:realizedThrough sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="expression" targetURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569"/></efrbr-structure:structureRelations><efrbr-responsible:responsibleRelations><efrbr-responsible:createdBy sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="2A62AA50-C78D-43BC-9B3F-5BAC79C39E33"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="2A62AA50-C78D-43BC-9B3F-5BAC79C39E33" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="50605E6C-A649-461E-A906-1CB066EA6201" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="E519FB47-4400-445E-B2BC-F97F938640DD" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="7E9E5222-5CB6-4F06-863D-6F55367972C8" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="B83DBACF-37F3-49C1-87A3-CB26D927DF24" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="E840FF49-B85D-4CA0-8521-7C1B22819928" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="63B72931-7075-470A-88DE-10819E279D9F" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="2565493B-B9C1-4217-A547-D92074DF73D9" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="CD9A1808-7F81-41CA-965A-6D9AD3C49628" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="2E288A78-F046-4A5F-B4E4-D16514349133" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="http://users.isc.tuc.gr/~dgournis" role="author"/><efrbr-responsible:realizedBy sourceEntity="expression" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="person" targetURI="https://v2.sherpa.ac.uk/id/publisher/30" role="publisher"/></efrbr-responsible:responsibleRelations><efrbr-subject:subjectRelations><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="CED34722-0D20-469D-88B7-969724B63AA2"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="92911702-2B56-4454-A8CF-0480A801F200"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="519EECC1-6AA9-46A6-BBAC-0BF451BA694E"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="F0A68654-65F9-4775-B1E8-1AD873275EFD"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="C3CFDD3A-6106-44D2-B41F-BB54241D9EA5"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="3A6BE53C-2AE2-45A7-A014-D84DF043009F"/><efrbr-subject:hasSubject sourceEntity="work" sourceURI="http://purl.tuc.gr/dl/dias/8A0548BD-98D6-4A5E-A110-00BB84DB0569" targetEntity="concept" targetURI="EDE9CB4B-9596-48A8-8551-93A2405BC8E6"/></efrbr-subject:subjectRelations><efrbr-other:otherRelations/></efrbr:relationships></efrbr:recordSet>